Skip to main content
Signal8
Launch Terminal
Kreitzer Anatol profile photo

Anatol Kreitzer

CIK: 0002021238

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)12 (75.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (18.8%)

Compensation grants

Other (G, F, J, C, D, …)1 (6.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MapLight Therapeutics, Inc. logo
MPLT

MapLight Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (16 total)

  • MapLight Therapeutics, Inc. logo
    MPLT

    MapLight Therapeutics, Inc.

    Oct 15, 2026
    Sale(S)
    Direct
    12.2K shares at avg. $7.84$96K
  • MapLight Therapeutics, Inc. logo
    MPLT

    MapLight Therapeutics, Inc.

    Aug 17, 2026
    Award(A)
    Direct
    6K shares-
  • MapLight Therapeutics, Inc. logo
    MPLT

    MapLight Therapeutics, Inc.

    Jul 17, 2026
    Sale(S)
    Direct
    200 shares at avg. $38.39$8K
  • MapLight Therapeutics, Inc. logo
    MPLT

    MapLight Therapeutics, Inc.

    Jul 17, 2026
    Sale(S)
    Direct
    14.1K shares at avg. $37.70$533K
  • MapLight Therapeutics, Inc. logo
    MPLT

    MapLight Therapeutics, Inc.

    Jul 17, 2026
    Sale(S)
    Direct
    2.8K shares at avg. $37.05$105K
  • MapLight Therapeutics, Inc. logo
    MPLT

    MapLight Therapeutics, Inc.

    Jul 16, 2026
    Sale(S)
    Direct
    1.6K shares at avg. $37.44$60K
  • MapLight Therapeutics, Inc. logo
    MPLT

    MapLight Therapeutics, Inc.

    Jul 16, 2026
    Sale(S)
    Direct
    7.5K shares at avg. $36.66$274K
  • MapLight Therapeutics, Inc. logo
    MPLT

    MapLight Therapeutics, Inc.

    Jul 15, 2026
    Sale(S)
    Direct
    5.5K shares at avg. $36.13$200K
  • MapLight Therapeutics, Inc. logo
    MPLT

    MapLight Therapeutics, Inc.

    Jul 15, 2026
    Sale(S)
    Direct
    4.5K shares at avg. $36.94$167K
  • MapLight Therapeutics, Inc. logo
    MPLT

    MapLight Therapeutics, Inc.

    Apr 27, 2026
    Sale(S)
    Direct
    29.3K shares at avg. $29.63$867K
  • MapLight Therapeutics, Inc. logo
    MPLT

    MapLight Therapeutics, Inc.

    Apr 27, 2026
    Sale(S)
    Direct
    8.3K shares at avg. $28.96$242K
  • MapLight Therapeutics, Inc. logo
    MPLT

    MapLight Therapeutics, Inc.

    Apr 27, 2026
    Sale(S)
    Direct
    7.8K shares at avg. $30.50$239K
  • MapLight Therapeutics, Inc. logo
    MPLT

    MapLight Therapeutics, Inc.

    Apr 15, 2026
    Sale(S)
    Direct
    3.3K shares at avg. $26.61$88K
  • MapLight Therapeutics, Inc. logo
    MPLT

    MapLight Therapeutics, Inc.

    Feb 5, 2026
    Award(A)
    Direct
    6K shares-
  • MapLight Therapeutics, Inc. logo
    MPLT

    MapLight Therapeutics, Inc.

    Jan 27, 2026
    Tax Payment(F)
    Direct
    42.1K shares at avg. $17.98$757K
  • MapLight Therapeutics, Inc. logo
    MPLT

    MapLight Therapeutics, Inc.

    Oct 27, 2025
    Award(A)
    Direct
    36K shares-

1-16 of 16

About Kreitzer Anatol

Kreitzer Anatol (SEC CIK 0002021238) files insider reports with the SEC as Chief Discovery Officer of MapLight Therapeutics, Inc. (MPLT).

Signal8 holds 9 ownership filings by Kreitzer Anatol (1 Form 3, 8 Form 4), filed between Oct 27, 2025 and Oct 16, 2026. Those filings report 16 transactions, from Oct 27, 2025 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kreitzer Anatol's filings is in REDWOOD CITY, CA.

Recent filings by Kreitzer Anatol

  • Oct 15, 2026: Open-market sale of MPLT shares (Form 4, code S).
  • Aug 17, 2026: Grant or award of MPLT shares (Form 4, code A).
  • Jul 17, 2026: Open-market sales of MPLT shares (3 lines, Form 4, code S).
  • Jul 16, 2026: Open-market sales of MPLT shares (2 lines, Form 4, code S).
  • Jul 15, 2026: Open-market sales of MPLT shares (2 lines, Form 4, code S).

Other insiders filing for MapLight Therapeutics, Inc. (MPLT)

How to read Form 4 transaction codes